Training on Pharmaceutical Sovereignty and Local Manufacturing

The COVID-19 pandemic exposed major vulnerabilities in global pharmaceutical supply chains and highlighted the strategic risks associated with heavy dependence on imported medicines, vaccines, medical consumables, and active pharmaceutical ingredients (APIs). Across Africa and the MENA region, many countries continue to import more than 70% of their pharmaceutical products, creating challenges related to affordability, access, health security, foreign exchange pressure, and industrial dependency.

As governments seek to strengthen health resilience and industrial capacity, pharmaceutical sovereignty has emerged as a strategic priority. Countries are increasingly pursuing policies that support local pharmaceutical manufacturing, regulatory harmonization, vaccine production, regional market integration, procurement reform, and technology transfer while improving compliance with international quality and safety standards.

This course provides advanced practical and policy-oriented training on pharmaceutical sovereignty and local manufacturing ecosystems. Participants learn how to strengthen domestic pharmaceutical production systems, modernize regulatory frameworks, improve Good Manufacturing Practices (GMP) compliance, expand vaccine manufacturing capacity, and redesign procurement systems to support local industry growth.

The program explores pharmaceutical industrial policy, regulatory harmonization, NAFDAC Five-Plus-Five policy frameworks, GMP upgrading, vaccine manufacturing systems, cold chain logistics, procurement reform, regional pharmaceutical trade, health security, industrial financing, technology transfer, and supply chain resilience. Participants also examine AfCFTA opportunities, regional pharmaceutical integration, ESG considerations, digital health manufacturing systems, and future trends in biotech and medical industrialization.

Through policy simulations, GMP assessments, procurement reform workshops, pharmaceutical manufacturing case studies, regulatory analysis exercises, and industrial planning scenarios, participants develop actionable frameworks for building resilient and competitive pharmaceutical manufacturing ecosystems.

Duration

10 Days

Who Should Attend

• Health ministry officials and policymakers
• Regulatory affairs managers
• Pharmaceutical manufacturers and executives
• Biotech entrepreneurs and innovators
• National medicines regulatory authorities
• Public procurement and supply chain officials
• Vaccine and biotechnology specialists
• GMP and quality assurance professionals
• Industrial policy and investment promotion agencies
• Pharmaceutical distribution and logistics managers
• Regional health and trade integration professionals

Individual Impact

• Strengthen expertise in pharmaceutical industrialization and regulation
• Improve understanding of GMP and pharmaceutical quality systems
• Enhance strategic planning for local manufacturing and health security
• Develop competency in vaccine manufacturing and logistics coordination
• Improve procurement reform and industrial policy design capabilities
• Strengthen leadership in pharmaceutical ecosystem development

Organizational Impact

• Improve domestic pharmaceutical production capacity
• Strengthen medicine security and supply chain resilience
• Enhance compliance with international quality standards
• Improve regional pharmaceutical competitiveness and export readiness
• Support local industry growth through procurement reform
• Reduce dependence on imported pharmaceutical products

By the end of this course, participants will be able to:

• Understand pharmaceutical sovereignty and industrial health security frameworks
• Strengthen local pharmaceutical manufacturing systems
• Apply GMP standards and international quality compliance frameworks
• Improve regulatory harmonization and market access strategies
• Develop vaccine manufacturing and cold chain logistics systems
• Design procurement systems that support local pharmaceutical industries
• Strengthen pharmaceutical supply chain resilience and industrial competitiveness
• Evaluate financing and investment opportunities in pharmaceutical manufacturing
• Integrate regional trade and AfCFTA opportunities into pharmaceutical strategy
• Build future-ready pharmaceutical and biotech industrial ecosystems

Module 1: Foundations of Pharmaceutical Sovereignty and Health Industrialization

• Pharmaceutical sovereignty and national health security
• Global pharmaceutical supply chain vulnerabilities
• Industrialization of healthcare manufacturing systems
• Strategic importance of domestic pharmaceutical production
• Regional pharmaceutical market opportunities
• Exercise: Pharmaceutical manufacturing ecosystem assessment
• Case Study: Pharmaceutical industrial transformation initiatives

Module 2: Regulatory Harmonization and Pharmaceutical Policy Reform

• Pharmaceutical regulatory systems and governance
• NAFDAC Five-Plus-Five policy and industrial implications
• Regulatory harmonization across EAC, ECOWAS, and AU systems
• Accelerating approvals while maintaining quality and safety
• Balancing industrial growth and public health protection
• Exercise: Regulatory harmonization policy workshop
• Case Study: Regulatory reforms supporting local manufacturing

Module 3: Good Manufacturing Practices (GMP) Upgrading

• Principles of Good Manufacturing Practices (GMP)
• Facility upgrading and quality management systems
• Validation, documentation, and operational compliance
• International standards for pharmaceutical exports
• Quality assurance and inspection readiness
• Exercise: GMP compliance assessment simulation
• Case Study: Pharmaceutical firms achieving international certification

Module 4: Pharmaceutical Manufacturing Operations and Industrial Scaling

• Scaling pharmaceutical production systems
• Active pharmaceutical ingredients (APIs) and formulation systems
• Manufacturing technologies and industrial efficiency
• Workforce skills and pharmaceutical technical capacity
• Operational risk management in pharmaceutical manufacturing
• Exercise: Pharmaceutical production planning workshop
• Case Study: Scaling local pharmaceutical production capacity

Module 5: Vaccine Manufacturing and Biotechnology Ecosystems

• Vaccine production systems and industrial requirements
• Biotech infrastructure and specialized manufacturing environments
• Technology transfer and strategic partnerships
• Research and innovation ecosystems for vaccine development
• Regulatory considerations in biologics manufacturing
• Exercise: Vaccine manufacturing ecosystem mapping
• Case Study: Emerging vaccine manufacturing hubs in Africa and MENA

Module 6: Cold Chain Logistics and Pharmaceutical Distribution

• Cold chain infrastructure and temperature-controlled logistics
• Distribution systems for vaccines and sensitive medical products
• Storage, transportation, and monitoring technologies
• Supply chain resilience and emergency preparedness
• Reducing pharmaceutical wastage and distribution risks
• Exercise: Cold chain logistics planning simulation
• Case Study: National vaccine distribution system modernization

Module 7: Procurement Reform and Local Manufacturing Prioritization

• Government procurement as an industrial policy tool
• Designing tenders that support local manufacturers
• Balancing affordability, competition, and industrial growth
• Strategic sourcing and public-private coordination
• Transparent procurement governance systems
• Exercise: Pharmaceutical procurement reform workshop
• Case Study: Procurement policies supporting local industry development

Module 8: Financing Pharmaceutical Industrialization

• Financing pharmaceutical infrastructure and manufacturing
• Public-private partnerships and blended finance models
• Development finance and industrial investment mechanisms
• Venture capital and biotech innovation funding
• Managing financial and operational risks
• Exercise: Pharmaceutical investment and financing simulations
• Case Study: Financing pharmaceutical industrial expansion

Module 9: Regional Trade, Export Readiness, and Market Integration

• AfCFTA and regional pharmaceutical trade opportunities
• Export readiness and regional regulatory alignment
• Pharmaceutical branding and market competitiveness
• Supply chain integration across regional blocs
• Strategic positioning in regional healthcare markets
• Exercise: Regional pharmaceutical market entry strategy
• Case Study: Cross-border pharmaceutical industrial integration

Module 10: Building Future-Ready Pharmaceutical Ecosystems

• Future trends in pharmaceutical manufacturing and biotech
• AI, automation, and digital systems in pharmaceutical production
• Sustainable pharmaceutical industrialization and ESG integration
• Strategic leadership in healthcare manufacturing ecosystems
• Long-term resilience and innovation planning
• Capstone Exercise: Develop a pharmaceutical sovereignty and local manufacturing framework
• Case Study: Future-ready pharmaceutical industrial ecosystems